Revium Rx RVRC
OTC RVRC
$1.43 +0.00 (+0.00%)
At close: Nov 10, 2026 · 4:00 PM EST

Revium Rx (RVRC) Net Cash Flow (2025 - 2026)

Updated

Revium Rx (RVRC) reported Net Cash Flow of -$1.59 million for FY2025, compared with -$2.03 million in FY2024.

Analysis

Revium Rx (RVRC) Net Cash Flow (2025 - 2026) Analysis & Trends

  • According to Business Quant data, Net Cash Flow came in at -$2.03 million in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) NCF (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -4.12 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -3.52 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 4.21 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 2.81 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 9.41 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -799.00 Mn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 3.26 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 843.00 Mn
10 Revium Rx 86.84 Mn 75.21 Mn - -78,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -78,000.00
Mar 31, 2026 -758,000.00
Jun 30, 2025 -263,000.00
Mar 31, 2025 643,000.00
API Access

Revium Rx Net Cash Flow API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-cash-flow&ticker=RVRC&period=max&api_key=YOUR_API_KEY